{
  "id": 1769614688638,
  "seqId": 121,
  "title": "Choroidal Melanoma: Clinical Essentials & Management",
  "summary": "The most common primary intraocular malignancy in adults, Choroidal Melanoma is a distinct molecular entity from cutaneous melanoma, often presenting as a dome-shaped mass that requires precise multimodal imaging and individualized treatment strategies.",
  "date": "2026-01-28T15:38:08.638Z",
  "data": {
    "title": "Choroidal Melanoma: Clinical Essentials & Management",
    "summary": "The most common primary intraocular malignancy in adults, Choroidal Melanoma is a distinct molecular entity from cutaneous melanoma, often presenting as a dome-shaped mass that requires precise multimodal imaging and individualized treatment strategies.",
    "summary_illustration": "<svg viewBox='0 0 100 100' xmlns='http://www.w3.org/2000/svg'><circle cx='50' cy='50' r='45' fill='none' stroke='#1d4ed8' stroke-width='2'/><path d='M20 50 Q50 10 80 50 Q50 90 20 50' fill='none' stroke='#1d4ed8' stroke-width='1'/><path d='M40 75 Q50 60 65 72' fill='#92400e' stroke='#451a03' stroke-width='1'/><circle cx='50' cy='50' r='10' fill='#1d4ed8'/></svg>",
    "sections": [
      {
        "title": "Core Characteristics & Epidemiology",
        "icon": "biotech",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Choroidal melanoma is the most common primary intraocular malignancy in adults.",
          "Accounts for 80% of all uveal melanomas.",
          "Still relatively uncommon overall.",
          "Tumours lack the most typical cutaneous melanoma-associated mutations.",
          "Characterized by a different set of genes.",
          "Predisposing factors are as for iris melanoma (above).",
          "Presentation peaks at around the age of 60 years.",
          "Most cases occur sporadically.",
          "Distinct molecular features differ from those found in cutaneous melanoma."
        ]
      },
      {
        "title": "Histopathological Classification",
        "icon": "microscopy",
        "type": "table",
        "layout": "half_width",
        "color_theme": "purple",
        "content": {
          "headers": [
            "Feature",
            "Spindle Cells (Fig. 20.25A)",
            "Epithelioid Cells (Fig. 20.25B)"
          ],
          "rows": [
            [
              "Morphology",
              "Tightly arranged fusiform cells; indistinct cell membranes; slender or plump oval nuclei.",
              "Large pleomorphic cells; distinct cell membranes; large vesicular nuclei; prominent nucleoli; abundant cytoplasm."
            ],
            [
              "Arrangement",
              "Arranged in bundles.",
              "More frequent mitotic figures."
            ],
            [
              "Prognosis",
              "Better prognosis.",
              "Worse prognosis; larger and more pleomorphic."
            ],
            [
              "Composition",
              "Commonly exclusively spindle cell.",
              "Commonly a mixture of spindle and epithelioid."
            ]
          ]
        }
      },
      {
        "title": "Growth Patterns & Metastatic Spread",
        "icon": "account_tree",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "red",
        "content": {
          "center": "Tumour Progression",
          "branches": [
            "Bruch Membrane/RPE Penetration: Leads to herniation into subretinal space, classically assuming the shape of a 'collar stud' (Fig. 20.25C).",
            "Local Invasion: Scleral channel and vortex vein invasion can lead to orbital spread.",
            "Metastasis: Commonly to the liver, bone and lung. Only 1–2% have detectable metastases at presentation.",
            "Mortality: Up to 50% at 10 years."
          ]
        }
      },
      {
        "title": "Adverse Prognostic Factors",
        "icon": "warning",
        "type": "red_flag",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Large numbers of epithelioid cells",
          "High mitotic activity",
          "Larger tumour dimensions",
          "Somatic mutations in tumour suppressor gene BAP1 (present in nearly 50% of uveal melanomas; implies greater chance of metastasis)",
          "Extrascleral extension",
          "Anterior location"
        ]
      },
      {
        "title": "Clinical Diagnosis: Signs & Symptoms",
        "icon": "visibility",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Symptoms: Often absent; detected by chance on routine fundus examination. A range of visual disturbance can occur.",
          "Solitary elevated subretinal grey-brown (Fig. 20.26A) or rarely amelanotic (Fig. 20.26B) dome-shaped mass.",
          "Diffuse infiltration is uncommon.",
          "Location: About 60% are within 3 mm of the optic disc (Fig. 20.26C) or fovea.",
          "Orange pigment: Clumps of overlying orange pigment are common (Fig. 20.26D).",
          "Bruch Breakthrough: 'Collar stud' appearance (Fig. 20.25C and Fig. 20.28C).",
          "Exudation: Associated haemorrhage and subretinal fluid (Fig. 20.26E); may result in exudative retinal detachment (Fig. 20.26F) masking the lesion.",
          "Other signs: Sentinel vessels (Fig. 20.27), choroidal folds, inflammation, rubeosis iridis, secondary glaucoma, and cataract."
        ]
      },
      {
        "title": "Differential Diagnosis: Pigmented Lesions",
        "icon": "compare",
        "type": "table",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Entity",
            "Distinguishing Features"
          ],
          "rows": [
            [
              "Choroidal Naevus",
              "Usually exhibits numerous surface drusen, without serous retinal detachment and little if any orange pigment."
            ],
            [
              "Melanocytoma",
              "Deeply pigmented and usually located at the optic disc."
            ],
            [
              "Congenital Hypertrophy of RPE (CHRPE)",
              "Flat, often grey-black, well-defined margin with lacunae."
            ],
            [
              "Haemorrhage",
              "Subretinal or suprachoroidal space (e.g., from CNV or retinal artery macroaneurysm)."
            ],
            [
              "Metastatic Cutaneous Melanoma",
              "Smooth surface, light brown colour, indistinct margins, extensive retinal detachment, often past history of malignancy."
            ]
          ]
        }
      },
      {
        "title": "Differential Diagnosis: Non-Pigmented Lesions",
        "icon": "search",
        "type": "table",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Entity",
            "Distinguishing Features"
          ],
          "rows": [
            [
              "Circumscribed Choroidal Haemangioma",
              "Typically posterior, pink, dome-shaped, smooth surface."
            ],
            [
              "Metastasis",
              "Often associated with exudative retinal detachment."
            ],
            [
              "Choroidal Granuloma",
              "Solitary, e.g., sarcoidosis, tuberculosis."
            ],
            [
              "Posterior Scleritis",
              "Large elevated lesion; unlike melanoma, pain is a common feature."
            ],
            [
              "Large Elevated CNV Lesion",
              "Eccentrically located (temporal pre-equatorial), associated with exudate and fresh haemorrhage (rare in melanoma)."
            ],
            [
              "Vortex Vein Ampulla",
              "Small, smooth, brown, dome-shaped; disappears with pressure on the eye."
            ]
          ]
        }
      },
      {
        "title": "Multimodal Ocular Investigations",
        "icon": "settings_suggest",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "yellow",
        "content": [
          "Examination: Sufficient for diagnosis in the majority of cases.",
          "FA (Fluorescein Angiography): Limited value (no pathognomonic pattern). Shows intrinsic tumour ('dual') circulation (Fig. 20.28A), mottled fluorescence, late diffuse leakage/staining.",
          "Ultrasound: Measures dimensions; detects tumours through opaque media. Key findings: internal homogeneity, low to medium reflectivity, choroidal excavation (Fig. 20.28B), orbital shadowing, and 'acoustic hollowing'.",
          "FAF (Fundus Autofluorescence): Intense diffuse or confluent hyperautofluorescence is a useful diagnostic indicator.",
          "OCT (Optical Coherence Tomography): Measures dimensions; shows subretinal fluid and secondary retinal changes overlying the lesion.",
          "ICGA (Indocyanine Green Angiography): Usually hypofluorescence; shows extent better than FA due to lower RPE interference.",
          "MRI (Fig. 20.28D): Useful for extraocular extension and differential diagnosis.",
          "Biopsy: Fine needle or 25-gauge vitrectomy system (larger sample) when diagnosis is uncertain.",
          "Immunocytochemistry: PAX8 expression. Melanoma/Melanocytoma are PAX8-negative; pigmented adenocarcinomas are PAX8-positive."
        ]
      },
      {
        "title": "Genetic Analysis & Prognostication",
        "icon": "dna",
        "type": "remember",
        "layout": "half_width",
        "color_theme": "purple",
        "content": {
          "mnemonic": "Genetic Poor Outcomes",
          "explanation": "Simple chromosomal changes: Loss of one copy of chromosome 3 (M3) and changes in chromosome 8 (i8q) strongly correlate with poor outcome, especially if concurrent. Metastasis occurs almost exclusively with certain genetic profiles."
        }
      },
      {
        "title": "Systemic Investigation & Monitoring",
        "icon": "monitor_heart",
        "type": "process",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "1. Aim: Detect metastatic spread or primary tumour elsewhere.",
          "2. Mainstays: Liver function testing and ultrasonography.",
          "3. Chest Radiography: Rarely shows lung secondaries without liver disease.",
          "4. PET/CT: Greater sensitivity for extrahepatic lesions; involves substantial ionizing radiation.",
          "5. Prognostic Tools: Liverpool Uveal Melanoma Prognosticator (online) determines life prognosis.",
          "6. Stratification: Reduced surveillance for low-risk genetic profiles."
        ]
      },
      {
        "title": "Treatment Strategy: Brachytherapy",
        "icon": "radioactive",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Goal: Avoid painful/unsightly eye; conserve vision.",
          "Indications: Tumours < 20 mm basal diameter and up to 10 mm thick with chance of salvaging vision.",
          "Method: Episcleral plaque sutured to sclera (Fig. 20.29A) for several days.",
          "Survival: Similar to enucleation.",
          "Regression: Begins 1–2 months post-treatment; continues over years; leaves flat/dome-shaped pigmented scar (Fig. 20.29B).",
          "Complications: Cataract, papillopathy (± disc neovascularization), radiation retinopathy.",
          "Toxic Tumour Syndrome: Release of cytokines causing retinopathy; may need endo/exoresection or intravitreal steroid/anti-VEGF."
        ]
      },
      {
        "title": "Alternative Radiotherapy & Laser",
        "icon": "Flash_on",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": [
          "External Beam Radiotherapy: Fractionated charged particles (protons). High dose to tumour, sparing adjacent tissues. Used for large or posterior tumours. Tantalum markers used for targeting.",
          "Stereotactic Radiotherapy: Multiple collimated beams. High radiation dose to tumour; comparatively high complication rate.",
          "Transpupillary Thermotherapy (TTT): Infrared laser inducing hyperthermia. Used for small tumours or adjunct to radiotherapy. Local recurrence common if thick, amelanotic, or at disc margin.",
          "TTT Complications: Retinal traction, tear, rhegmatogenous detachment, vascular occlusion, neovascularization."
        ]
      },
      {
        "title": "Surgical & Novel Interventions",
        "icon": "medical_services",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Trans-scleral Choroidectomy: Technically difficult. Used for tumours too thick for radiotherapy but < 16 mm. Complications: RD, hypotony, wound dehiscence, recurrence.",
          "Light-activated AU-011: Novel treatment for small melanomas (2–3.4 mm). Nano-particles from HPV + infrared dye injected intravitreally. Infrared activation causes selective necrosis.",
          "Enucleation: Indications include large size, disc invasion, extensive ciliary body/angle involvement, irreversible vision loss, or poor patient motivation to keep eye.",
          "Enucleation Safety: Perform ophthalmoscopy after draping to ensure correct eye is removed; minimize eye manipulation."
        ]
      },
      {
        "title": "Metastatic Disease Management",
        "icon": "biotech",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "No standard treatment for metastatic disease.",
          "Tebentafusc (immunotherapy): Modest increase in overall survival for some patients.",
          "Immune checkpoint inhibitors: Effective for cutaneous melanoma, but NOT effective against uveal melanoma.",
          "Systemic chemotherapy: Not shown to be of benefit where no evidence of metastatic spread exists."
        ]
      },
      {
        "title": "Statistical Overview",
        "icon": "bar_chart",
        "type": "chart",
        "layout": "full_width",
        "color_theme": "purple",
        "content": {
          "type": "bar",
          "data": [
            {
              "label": "Uveal Melanomas that are Choroidal",
              "value": 80
            },
            {
              "label": "10-Year Mortality Rate",
              "value": 50
            },
            {
              "label": "Cases with BAP1 Mutation",
              "value": 50
            },
            {
              "label": "Located within 3mm of Disc/Fovea",
              "value": 60
            },
            {
              "label": "Detectible Metastasis at Presentation",
              "value": 2
            }
          ]
        }
      }
    ],
    "chapterId": "tumours"
  },
  "chapterId": "tumours",
  "_newlyImported": 1769614688638,
  "communityId": "sub_1769609169726_nuu7jj5rw",
  "communityAuthor": "Dodi",
  "communityDate": "2026-01-28T14:06:09.726Z",
  "_serverSynced": true
}